GSK PLC Director/PDMR Shareholding (2583Z)
13 Septiembre 2022 - 3:11AM
UK Regulatory
TIDMGSK
RNS Number : 2583Z
GSK PLC
13 September 2022
GSK plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Ms E Walmsley
=== ============================ =====================================================
b) Position/status Chief Executive Officer
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr R Connor
=== ============================ =====================================================
b) Position/status President, Vaccines and Global Health
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr J Ford
=== ============================ =====================================================
b) Position/status SVP and Group General Counsel, Legal and
Compliance
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Ms S Jackson
=== ============================ =====================================================
b) Position/status SVP, Global Communications and CEO Office
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr D Jackson
=== ============================ =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr D Redfern
=== ============================ =====================================================
b) Position/status President Corporate Development
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr R Simard
=== ============================ =====================================================
b) Position/status President, Global Supply Chain
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr P Thomson
=== ============================ =====================================================
b) Position/status President, Global Affairs
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =================================
GBP13.6209 10 (partnership shares)
=== ============================ ============== =================================
GBP13.6209 10 (matching shares)
============== =================================
d) Aggregated information
===
Aggregated volume 20 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Ms D Waterhouse
=== ============================ =====================================================
b) Position/status CEO, ViiV Healthcare
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Ms V Whyte
=== ============================ =====================================================
b) Position/status Company Secretary
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP13.6209 9 (partnership shares)
=== ============================ ================ ===============================
GBP13.6209 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6209
=== ============================ =====================================================
e) Date of the transaction 2022-09-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHSFUSADEESESU
(END) Dow Jones Newswires
September 13, 2022 04:11 ET (08:11 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
